Synergistic Effect of the CHA2DS2-VASc Score and Left Atrial Epicardial Adipose Tissue Volume on Predicting Atrial
Chuanyi Sang1, Renjie Gu1, Tian Xia1
1Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou, 225000, People's Republic of China.
Insights
Combining CHA2DS2-VASc score and left atrial epicardial adipose tissue (LA-EAT) volume significantly increases atrial fibrillation (AF) recurrence risk after ablation. This combined assessment improves prediction of AF recurrence post-ablation.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Imaging
Background:
- Atrial fibrillation (AF) recurrence post-ablation is a clinical challenge.
- CHA2DS2-VASc score and left atrial epicardial adipose tissue (LA-EAT) volume are known AF risk factors.
- The interaction between these risk factors for AF recurrence remains understudied.
Purpose of the Study:
- To evaluate the combined predictive potential of CHA2DS2-VASc score and LA-EAT volume for AF recurrence after ablation.
- To investigate the synergistic interaction between CHA2DS2-VASc score and LA-EAT volume in predicting AF recurrence.
Main Methods:
- A cohort of 507 patients undergoing AF ablation was followed for 12 months.
- AF recurrence was defined by ECG-documented AF or atrial tachycardia >30 seconds.
- Cox regression and interaction analyses (RERI, AP, SI) assessed risk and synergy.
Main Results:
- 140 patients (27.6%) experienced AF recurrence.
- Both CHA2DS2-VASc score and LA-EAT volume were independent predictors of recurrence.
- A significant synergistic interaction was found between CHA2DS2-VASc score and LA-EAT volume, enhancing predictive capabilities.
Conclusions:
- A significant additive interaction exists between CHA2DS2-VASc score and LA-EAT volume.
- The combination of these factors substantially increases AF recurrence risk post-ablation.
- Integrating LA-EAT volume with clinical models improves AF recurrence prediction accuracy.
Objective:
The CHA2DS2-VASc score and left atrial epicardial adipose tissue (LA-EAT) volume have been identified as potential risk factors for atrial fibrillation (AF) recurrence after ablation. However, there is currently a lack of research specifically examining the interaction between these two AF risk factors. This study aims to evaluate the predictive potential of combining CHA2DS2-VASc score and LA-EAT volume in predicting recurrence in patients with AF who undergo ablation.
Methods:
The study encompassed a cohort of 507 patients who underwent ablation for AF finally. Follow-up assessments were conducted 1, 3, 6, and 12 months after ablation, including clinical evaluation, a 12-lead ECG, and 24-hour Holter monitoring. Recurrence was characterized by symptomatic or asymptomatic AF episodes or atrial tachycardia lasting more than 30 seconds, as evidenced by any ECG following the 3-month BP. Patients were stratified into groups based on the defined cut-off values of CHA2DS2-VASc score and LA-EAT volume. Cox regression analysis was employed to estimate the risk factor of AF recurrence after ablation. The interaction between CHA2DS2-VASc score and LA-EAT volume was assessed using the relative excess risk due to interaction (RERI), attributable proportion (AP), and synergy index (SI).
Results:
140 patients experienced AF recurrence after ablation during the follow-up period. Multivariable Cox regression analysis demonstrated that CHA2DS2-VASc score and LA-EAT volume were independent risk factors for AF recurrence. Patients with higher CHA2DS2-VASc score and LA-EAT volume exhibited a higher risk of recurrence than those with lower score and volume. Furthermore, a significant synergistic interaction existed between CHA2DS2-VASc score and LA-EAT volume. The LA-EAT volume and clinical model combination improved the predictive value reclassification, and discriminant abilities improved significantly.
Conclusion:
There is a significant additive interaction between CHA2DS2-VASc score and LA-EAT volume, with the coexistence of both factors significantly increasing the risk of AF recurrence after ablation.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Complexation Equilibria: The Chelate Effect
Prochirality


